Candriam SCA’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $62.5M | Sell |
586,736
-84,219
| -13% | -$8.97M | 0.36% | 70 |
|
2025
Q1 | $61.1M | Sell |
670,955
-175,979
| -21% | -$16M | 0.38% | 60 |
|
2024
Q4 | $96.5M | Sell |
846,934
-80,230
| -9% | -$9.14M | 0.56% | 32 |
|
2024
Q3 | $110M | Buy |
927,164
+348,166
| +60% | +$41.3M | 0.63% | 29 |
|
2024
Q2 | $46.5M | Buy |
578,998
+418,695
| +261% | +$33.6M | 0.28% | 78 |
|
2024
Q1 | $14.8M | Buy |
160,303
+120,000
| +298% | +$11.1M | 0.09% | 208 |
|
2023
Q4 | $4.25M | Sell |
40,303
-20,000
| -33% | -$2.11M | 0.03% | 352 |
|
2023
Q3 | $6.55M | Sell |
60,303
-82,000
| -58% | -$8.91M | 0.05% | 281 |
|
2023
Q2 | $15.4M | Sell |
142,303
-10,080
| -7% | -$1.09M | 0.11% | 193 |
|
2023
Q1 | $17.5M | Hold |
152,383
| – | – | 0.12% | 186 |
|
2022
Q4 | $22.9M | Sell |
152,383
-63,033
| -29% | -$9.47M | 0.15% | 154 |
|
2022
Q3 | $29.1M | Sell |
215,416
-22,718
| -10% | -$3.07M | 0.21% | 108 |
|
2022
Q2 | $35.5M | Sell |
238,134
-4,000
| -2% | -$596K | 0.29% | 85 |
|
2022
Q1 | $41.3M | Buy |
242,134
+1,232
| +0.5% | +$210K | 0.28% | 87 |
|
2021
Q4 | $61.6M | Buy |
240,902
+127,705
| +113% | +$32.6M | 0.39% | 60 |
|
2021
Q3 | $30.9M | Buy |
113,197
+9,100
| +9% | +$2.48M | 0.21% | 118 |
|
2021
Q2 | $23.3M | Buy |
104,097
+16,336
| +19% | +$3.66M | 0.16% | 153 |
|
2021
Q1 | $6.87M | Hold |
87,761
| – | – | 0.06% | 318 |
|
2020
Q4 | $7.15M | Sell |
87,761
-259,776
| -75% | -$21.2M | 0.06% | 326 |
|
2020
Q3 | $24.1M | Sell |
347,537
-62,776
| -15% | -$4.35M | 0.23% | 111 |
|
2020
Q2 | $27.4M | Buy |
+410,313
| New | +$27.4M | 0.29% | 91 |
|